| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.4 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |